Università Cattolica del Sacro Cuore, known as UCSC or UNICATT or simply Cattolica, is an Italian private research university founded in 1921. Cattolica, with its five affiliated campuses, is the largest private university in Europe and the largest Catholic University in the world.

During the past decade, Catholic University of Sacred Heart conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 4 clinical trials were completed, i.e. on average, 14.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Catholic University of Sacred Heart" #1 sponsor was "Catholic University of the Sacred Heart" with 62 trials, followed by "Fondazione Policlinico Universitario Agostino Gemelli IRCCS" with 2 trials sponsored, "Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne" with 2 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials sponsored and "Canadian Research & Education in Arthritis" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Catholic University of Sacred Heart" #1 collaborator was "Catholic University of the Sacred Heart" with 3 trials as a collaborator, "Fagotti, Anna, M.D." with 3 trials as a collaborator, "Fanfani, Francesco, M.D." with 3 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Catholic University of Sacred Heart" are "Polycystic Ovary Syndrome" (7 trials), "Coronary Artery Disease" (5 trials), "Asthma" (2 trials), "Coronary Stenosis" (2 trials) and "Endometrial Cancer" (2 trials). Many other conditions were trialed in "Catholic University of Sacred Heart" in a lesser frequency.

Most popular intervention types in "Catholic University of Sacred Heart" are "Drug" (29 trials), "Procedure" (20 trials), "Device" (15 trials), "Other" (11 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "3D Laparoscopy" (2 trials), "Everolimus eluting stent" (2 trials), "Metformin" (2 trials), "Sirolimus eluting stent" (2 trials) and "Standard Laparoscopy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Catholic University of Sacred Heart" are 46 trials for "All" genders, 31 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Catholic University of Sacred Heart". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Catholic University of Sacred Heart, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Catholic University of Sacred Heart, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 28 trials that are defined as “Not Applicable".